PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Sarepta Therapeutics, Inc.
Filed: May 6, 2011
Period of Report: June 13, 2011
Accession Number: 0001193125-11-130840

View Document ↗ View on SEC.gov ↗